Bruno Cacopardo

University of Catania School of Medicine - Department of Internal and Experimental Medicine

SCHOLARLY PAPERS

1

DOWNLOADS

123

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Real-Life Comparison of Mortality in Non-Hospitalised Patients with SARS-CoV-2 Infection at Risk for Clinical Progression Treated with Molnupiravir or Nirmatrevir Plus Ritonavir During the Omicron Era in Italy: A Nationwide, Observational Study

Number of pages: 35 Posted: 10 May 2023
Magna Graecia University of Catanzaro - Department of Medical and Surgical Sciences, The Italian Medicines Agency (AIFA), University of Milano-Bicocca - Fondazione IRCCS San Gerardo dei Tintori, Udine University Hospital - Department of Medicine (DAME), Infectious Diseases Clinic, The Italian Medicines Agency (AIFA), San Donato Hospital - Department of Specialised and Internal Medicine, Infectious Diseases Unit, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, University of Verona - Infectious Diseases, Department of Diagnostic and Public Health, University of Catania School of Medicine - Department of Internal and Experimental Medicine, D. Cotugno Hospital - Division Emerging Infectious Disease and High Contagiousness, San Giuseppe Moscati Hospital - Infectious Diseases Unit, Pescara General Hospital - Department of Medicine, Infectious Disease Unit, University of Genoa - Department of Health Sciences (DISSAL), Infermi Hospital, AUSL Romagna - Unit of Infectious Disease, Azienda Ospedaliera Universitaria - Ospedali Riuniti di Ancona, Central Hospital of Bolzano - Department of Infectious Disease, A.O.R. San Carlo - Infectious Diseases Unit, Santa Chiara Hospital - Infectious Diseases Unit, Department of Medical, The Italian Medicines Agency (AIFA), Sapienza University of Rome - Department of Public Health and Infectious Diseases, Sapienza University of Rome - Department of Public Health and Infectious Diseases, University of Torino - Unit of Infectious Diseases, Italian Medicines Agency and The Italian Medicines Agency (AIFA)
Downloads 123 (468,731)

Abstract:

Loading...

COVID-19, SARS-CoV-2, nirmatrelvir/ritonavir, molnupiravir, real-world, effectiveness